QuANTUM-First Trial: FLT3-Internal Tandem Duplication (FLT3-ITD)-Specific Measurable Residual Disease (MRD) Clearance Is Associated With Improved Overall Survival (OS)-MedSci.cn

QuANTUM-First Trial: FLT3-Internal Tandem Duplication (FLT3-ITD)-Specific Measurable Residual Disease (MRD) Clearance Is Associated With Improved Overall Survival (OS)

Levis, MJ; Erba, HP; Montesinos, P; Vrhovac, R; Patkowska, E; Kim, HJ; Zak, P; Wang, PN; Rohrbach, JEC; Chang, KCN; Hanyok, J; Liu, L; Kamel, YM; Lesegretain, A; Cortes, J; Sekeres, MA; Dombret, H; Amadori, S; Wang, JX; Schlenk, RF; Perl, AE

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023; 23 (): S272

科室
- - 订阅+
  - 更多科室
工具
服务